Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply.
Publication
, Journal Article
Henson, JB; Corey, KE
Published in: Alimentary pharmacology & therapeutics
May 2020
Duke Scholars
Published In
Alimentary pharmacology & therapeutics
DOI
EISSN
1365-2036
ISSN
0269-2813
Publication Date
May 2020
Volume
51
Issue
10
Start / End Page
988 / 989
Related Subject Headings
- Risk Factors
- Non-alcoholic Fatty Liver Disease
- Liver Cirrhosis
- Humans
- Gastroenterology & Hepatology
- Fibrosis
- Cardiovascular Diseases
- 3214 Pharmacology and pharmaceutical sciences
- 3202 Clinical sciences
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Henson, J. B., & Corey, K. E. (2020). Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply. Alimentary Pharmacology & Therapeutics, 51(10), 988–989. https://doi.org/10.1111/apt.15696
Henson, Jacqueline B., and Kathleen E. Corey. “Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply.” Alimentary Pharmacology & Therapeutics 51, no. 10 (May 2020): 988–89. https://doi.org/10.1111/apt.15696.
Henson JB, Corey KE. Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply. Alimentary pharmacology & therapeutics. 2020 May;51(10):988–9.
Henson, Jacqueline B., and Kathleen E. Corey. “Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply.” Alimentary Pharmacology & Therapeutics, vol. 51, no. 10, May 2020, pp. 988–89. Epmc, doi:10.1111/apt.15696.
Henson JB, Corey KE. Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply. Alimentary pharmacology & therapeutics. 2020 May;51(10):988–989.
Published In
Alimentary pharmacology & therapeutics
DOI
EISSN
1365-2036
ISSN
0269-2813
Publication Date
May 2020
Volume
51
Issue
10
Start / End Page
988 / 989
Related Subject Headings
- Risk Factors
- Non-alcoholic Fatty Liver Disease
- Liver Cirrhosis
- Humans
- Gastroenterology & Hepatology
- Fibrosis
- Cardiovascular Diseases
- 3214 Pharmacology and pharmaceutical sciences
- 3202 Clinical sciences
- 1115 Pharmacology and Pharmaceutical Sciences